D28.2 可计费的具体编码 Benign neoplasm of uterine tubes and ligaments
ICD-10-CM D28.2 identifies “Benign neoplasm of uterine tubes and ligaments” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
章节 2: Neoplasms
编码说明
Inclusion terms2
- Benign neoplasm of fallopian tube
- Benign neoplasm of uterine ligament (broad) (round)
上级编码说明
章节 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
D28 · Benign neoplasm of other and unspecified female genital organs
Includes3
- adenomatous polyp
- benign neoplasm of skin of female genital organs
- benign teratoma
官方索引引用
官方索引引用 (24)
Endosalpingioma (1)
- Endosalpingioma疾病索引
Neoplasm, neoplastic (23)
- Neoplasm, neoplastic › broad ligament肿瘤
- Neoplasm, neoplastic › fallopian tube(accessory)肿瘤
- Neoplasm, neoplastic › ligament › broad肿瘤
- Neoplasm, neoplastic › ligament › round肿瘤
- Neoplasm, neoplastic › ligament › sacro-uterine肿瘤
- Neoplasm, neoplastic › ligament › uterine肿瘤
- Neoplasm, neoplastic › ligament › utero-ovarian肿瘤
- Neoplasm, neoplastic › ligament › uterosacral肿瘤
- Neoplasm, neoplastic › mesosalpinx肿瘤
- Neoplasm, neoplastic › mesovarium肿瘤
- Neoplasm, neoplastic › oviduct肿瘤
- Neoplasm, neoplastic › parametrium肿瘤
- Neoplasm, neoplastic › paroophoron肿瘤
- Neoplasm, neoplastic › parovarium肿瘤
- Neoplasm, neoplastic › round ligament肿瘤
- Neoplasm, neoplastic › sacrouterine ligament肿瘤
- Neoplasm, neoplastic › salpinx(uterine)肿瘤
- Neoplasm, neoplastic › utero-ovarian › ligament肿瘤
- Neoplasm, neoplastic › uterosacral ligament肿瘤
- Neoplasm, neoplastic › uterus, uteri, uterine › ligament肿瘤
- Neoplasm, neoplastic › uterus, uteri, uterine › ligament › broad肿瘤
- Neoplasm, neoplastic › uterus, uteri, uterine › ligament › round肿瘤
- Neoplasm, neoplastic › uterus, uteri, uterine › tube肿瘤
其他编码的引用 (2)
Excludes 1 · benign neoplasm of uterine ligament, any (D28.2)
Excludes 1 · benign neoplasm of any uterine ligament (D28.2)
历史
编码历史
自首次收录以来无变更记录
已变更无变更
FY2016
生效日期
- 首次收录
Benign neoplasm of uterine tubes and ligaments
可用于账单的诊断编码
CDC/NCHS · FY2016所有版本 (19)
| 所有版本 | 生效日期 | 编码历史 |
|---|---|---|
| FY2016 | 2015-10-01 | 首次收录 |
| FY2017 | 2016-10-01 | 分类表无变更 |
| FY2018 | 2017-10-01 | 分类表无变更 |
| FY2019 | 2018-10-01 | 分类表无变更 |
| FY2020 | 2019-10-01 | 分类表无变更 |
| FY2020 · April | 2020-04-01 | 分类表无变更 |
| FY2021 | 2020-10-01 | 分类表无变更 |
| FY2021 · 01-01 | 2021-01-01 | 分类表无变更 |
| FY2022 | 2021-10-01 | 分类表无变更 |
| FY2022 · 04-01 | 2022-04-01 | 分类表无变更 |
| FY2023 | 2022-10-01 | 分类表无变更 |
| FY2023 · 04-01 | 2023-04-01 | 分类表无变更 |
| FY2024 | 2023-10-01 | 分类表无变更 |
| FY2024 · 04-01 | 2024-04-01 | 分类表无变更 |
| FY2025 | 2024-10-01 | 分类表无变更 |
| FY2025 · 04-01 | 2025-04-01 | 分类表无变更 |
| FY2026 | 2025-10-01 | 分类表无变更 |
| FY2026 · April | 2026-04-01 | 分类表无变更 |
| FY2027 | 2026-10-01 | 分类表无变更 |
历史 ICD-9 映射 · 2018
仅为历史映射,不可自动替换编码。
- 221.0
此条目是所选版本中的完整编码。 参考核验不能确定临床适用性,也不保证报销。